Leuprolide Acetate Induces Structural and Functional Recovery of Injured Spinal Cord in Rats
Overview
Authors
Affiliations
Gonadotropin-releasing hormone (GnRH) and its synthetic analog leuprolide acetate, a GnRH agonist, have neurotrophic properties. This study was designed to determine whether administration of leuprolide acetate can improve locomotor behavior, gait, micturition reflex, spinal cord morphology and the amount of microglia in the lesion epicenter after spinal cord injury in rats. Rats with spinal cord compression injury were administered leuprolide acetate or saline solution for 5 weeks. At the 5(th) week, leuprolide acetate-treated rats showed locomotor activity recovery by 38%, had improvement in kinematic gait and exhibited voiding reflex recovery by 60%, as compared with the 1(st) week. By contrast, saline solution-treated rats showed locomotor activity recovery only by 7%, but voiding reflex did not recover. More importantly, leuprolide acetate treatment reduced microglial immunological reaction and induced a trend towards greater area of white and gray matter in the spinal cord. Therefore, leuprolide acetate has great potential to repair spinal cord injury.
SPATIAL MEMORY RECOVERY IN AGED MALE RATS TREATED WITH LEUPROLIDE ACETATE, A GNRH AGONIST.
Macedo-Mendoza M, Calderon-Vallejo D, Gonzalez-Torres M, Martinez-Martinez A, Gasca-Martinez D, Orta Salazar E Acta Endocrinol (Buchar). 2025; 20(2):127-135.
PMID: 39845751 PMC: 11750219. DOI: 10.4183/aeb.2024.127.
Martinez-Moreno C, Calderon-Vallejo D, Diaz-Galindo C, Hernandez-Jasso I, Olivares-Hernandez J, Avila-Mendoza J Sci Rep. 2024; 14(1):26420.
PMID: 39488642 PMC: 11531546. DOI: 10.1038/s41598-024-78073-3.
Gutierrez-Esparza B, Gonzalez-Torres M, Quintanar-Stephano A, Quintanar J Metab Brain Dis. 2024; 39(7):1447-1458.
PMID: 39177865 DOI: 10.1007/s11011-024-01413-9.
Martinez-Moreno C, Calderon-Vallejo D, Diaz-Galindo C, Hernandez-Jasso I, Olivares-Hernandez J, Avila-Mendoza J Front Neurosci. 2023; 17:1164044.
PMID: 37360158 PMC: 10288327. DOI: 10.3389/fnins.2023.1164044.
Ashmwe M, Posa K, Ruhrnossl A, Heinzel J, Heimel P, Mock M Biomedicines. 2022; 10(7).
PMID: 35884935 PMC: 9313454. DOI: 10.3390/biomedicines10071630.